The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study
Abstract
CONTEXT: After surgery for differentiated thyroid carcinoma, many patients are treated with radioiodine to ablate remnant thyroid tissue. This procedure has been performed with the patient in the hypothyroid state to promote endogenous TSH stimulation and is often associated with hypothyroid symptoms and impaired quality of life. OBJECTIVE AND INTERVENTION: This international, randomized, controlled, multicenter trial aimed to compare the efficacy and safety of recombinant human TSH (rhTSH) to prepare euthyroid patients on L-thyroxine therapy (euthyroid group) to ablate remnant thyroid tissue with 3.7 GBq (100 mCi) 131I, compared with that with conventional remnant ablation performed in the hypothyroid state (hypothyroid group). Quality of life was determined at the time of randomization and ablation. After the administration of the 131-I dose, the rate of radiation clearance from blood, thyroid remnant, and whole body was measured. RESULTS: The predefined primary criterion for successful ablation was "no visible uptake in the thyroid bed, or if visible, fractional uptake less than 0.1%" on neck scans performed 8 months after therapy and was satisfied in 100% of patients in both groups. A secondary criterion for ablation, an rhTSH-stimulated serum thyroglobulin concentration less than 2 ng/ml, was fulfilled by 23 of 24 (96%) euthyroid patients and 18 of 21 (86%) hypothyroid patients (P = 0.2341). Quality of life was well preserved in the euthyroid group, compared with the hypothyroid group, as demonstrated by their lower pretreatment scores on the Billewicz scale for hypothyroid signs and symptoms, 27 +/- 7 vs. 18 +/- 4 (P < 0.0001) and their significantly higher Short Form-36 Health Assessment Scale scores in five of eight categories. Euthyroid patients had a statistically significant one third lower radiation dose to the blood, compared with patients in the hypothyroid group. CONCLUSIONS: This study demonstrates comparable remnant ablation rates in patients prepared for 131I remnant ablation with 3.7 GBq by either administering rhTSH or withholding thyroid hormone. rhTSH-prepared patients maintained a higher quality of life and received less radiation exposure to the blood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Self-citation“Proving the null hypothesis” in clinical trials
Blackwelder, W. C. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90024-1 · Cited by 887
Second primary malignancies in thyroid cancer patients
Rubino, C., de Vathaire, F., Dottorini, M. E., Hall, P., Schvartz, C., Couette, J. E., Dondon, M. G., Abbas, M. T., Langlois, C., & Schlumberger, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601319 · Cited by 655
Self-citationMazzaferri, E. L., Robbins, R. J., Spencer, C. A., Braverman, L. E., Pacini, F., Wartofsky, L., Haugen, B. R., Sherman, S. I., Cooper, D. S., Braunstein, G. D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021702 · Cited by 654
Self-citationHaugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6094 · Cited by 566
Self-citationLadenson, P. W., Braverman, L. E., Mazzaferri, E. L., Brucker-Davis, F., Cooper, D. S., Garber, J. R., Wondisford, F. E., Davies, T. F., DeGroot, L. J., Daniels, G. H., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371304 · Cited by 466
Self-citationSawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., & Gerstein, H. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031167 · Cited by 432
Pacini, F., Molinaro, E., Castagna, M. G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L., & Pinchera, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021925 · Cited by 428
Self-citationRadioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
Maxon, H. R., & Smith, H. S. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30317-7 · Cited by 409
Cailleux, A. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.175 · Cited by 357
Hänscheid, H., Laßmann, M., Luster, M., Thomas, S. R., Pacini, F., Ceccarelli, C., Ladenson, P. W., Wahl, R. L., Schlumberger, M. J., Ricard, M., et al. (2006) · PubMed · Cited by 329
Self-citationFollow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
Schlumberger, M., Berg, G., Cohen, O., Duntas, L., Jamar, F., Jarzab, B., Limbert, E., Lind, P., Pacini, F., Reiners, C., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500105 · Cited by 327
Self-citationPacini, F. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1499 · Cited by 299
Self-citationQuality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy
DOW, K. H., FERRELL, B. R., & ANELLO, C. (1997) · Thyroid · doi:10.1089/thy.1997.7.613 · Cited by 289
Mazzaferri, E. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1490 · Cited by 262
Bartko, J. J. (1991) · American Psychologist · doi:10.1037//0003-066x.46.10.1089.a · Cited by 249
Pacini, F., Molinaro, E., Castagna, M. G., Lippi, F., Ceccarelli, C., Agate, L., Elisei, R., & Pinchera, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011918 · Cited by 176
Self-citationRobbins, R. J., Larson, S. M., Sinha, N., Shaha, A. R., Divgi, C. R., Pentlow, K. S., Ghossein, R. A., & Tuttle, R. M. (2002) · PubMed · Cited by 150
Barbaro, D., Boni, G., Meucci, G., Simi, U., Lapi, P., Orsini, P., Pasquini, C., Piazza, F., Caciagli, M., & Mariani, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030298 · Cited by 146
Determination of Total Iodine in Urine, Stool, Diets, and Tissue
Benotti, J. R., Benotti, N., Pino, S., & Gardyna, H. (1965) · Clinical Chemistry · doi:10.1093/clinchem/11.10.932 · Cited by 139
Johansen, K., Woodhouse, N. J. Y., & Odugbesan, O. (1991) · PubMed · Cited by 123
Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
Laßmann, M., Luster, M., Hänscheid, H., & Reiners, C. (2004) · PubMed · Cited by 119
Self-citationLuster, M., Sherman, S. I., Skarulis, M. C., Reynolds, J. R., Laßmann, M., H�nscheid, H., & Reiners, C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1230-1 · Cited by 114
Self-citationFeldt‐Rasmussen, U., Profilis, C., Colinet, E., Black, E. G., Bornet, H., Bourdoux, P. P., Carayon, P., Ericsson, U.-B. C., Koutras, D. A., León, L., et al. (1996) · PubMed · Cited by 66
Self-citation
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
“A prospective randomized study found that thyroid hormone withdrawal and rhTSH stimulation were equally effective in preparing patients for (131)I remnant ablation with 100 mCi with significantly improved quality of life (237).”
Self-citationThyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., & Berruti, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz400 · Cited by 1,200
Self-citationGuidelines for radioiodine therapy of differentiated thyroid cancer
Luster, M., Clarke, S. E., Dietlein, M., Lassmann, M., Lind, P., Oyen, W. J. G., Tennvall, J., & Bombardieri, E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0883-1 · Cited by 727
Self-citationStrategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Schlumberger, M., Catargi, B., Borget, I., Deandreis, D., Zerdoud, S., Bridji, B., Bardet, S., Leenhardt, L., Bastie, D., Schvartz, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108586 · Cited by 684
Self-citation
Metadata
- Authors
- Pacini, F., Ladenson, P. W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R. T., Sherman, S., Haugen, B., Corone, C., Molinaro, E., Elisei, R., Ceccarelli, C., Pinchera, A., Wahl, R. L., Leboulleux, S., Ricard, M., Yoo, J., Busaidy, N. L., Delpassand, E., Hanscheid, H., Felbinger, R., Lassmann, M., & Reiners, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-03
- Volume
- 91
- Issue
- 3
- Pages
- 926-932
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2108800970
- Cited by
- 450
- References
- 25
- FWCI
- 25.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.